SLC30A8, CDKAL1, TCF7L2, KCNQ1 and IGF2BP2 are Associated with Type 2 Diabetes Mellitus in Iranian Patients

References

• Nyenwe EA, Jerkins TW, Umpierrez GE, Kitabchi AE. Management of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetes. Metabolism. 2011;60(1):1–23. doi:10.1016/j.metabol.2010.09.010
   PubMed Web of Science ®Google Scholar
• Horikawa Y, Oda N, Cox NJ, et al. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet. 2000;26(2):163. doi:10.1038/79876
   PubMedGoogle Scholar
• Hu FB. Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care. 2011;34(6):1249–1257. doi:10.2337/dc11-0442
   PubMed Web of Science ®Google Scholar
• Timper K, Donath MY. Diabetes mellitus type 2-the new face of an old lady. Swiss Med Wkly. 2012;142:2930.
   Google Scholar
• Esteghamati A, Gouya MM, Abbasi M, et al. Prevalence of diabetes and impaired fasting glucose in the adult population of Iran: national survey of risk factors for non-communicable diseases of Iran. Diabetes Care. 2008;31(1):96–98. doi:10.2337/dc07-0959
   PubMed Web of Science ®Google Scholar
• Ridderstråle M, Groop L. Genetic dissection of type 2 diabetes. Mol Cell Endocrinol. 2009;297(1–2):10–17. doi:10.1016/j.mce.2008.10.002
   PubMedGoogle Scholar
• Gloyn AL, McCarthy MI. The genetics of type 2 diabetes. Best Pract Res Clin Endocrinol Metab. 2001;15(3):293–308. doi:10.1053/beem.2001.0147
   PubMedGoogle Scholar
• Christiansen J, Kolte AM, Nielsen FC. IGF2 mRNA-binding protein 2: biological function and putative role in type 2 diabetes. J Mol Endocrinol. 2009;43(5):187–195. doi:10.1677/JME-09-0016
   PubMedGoogle Scholar
• Zeggini E, Weedon MN, Lindgren CM, et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science. 2007;316(5829):1336–1341. doi:10.1126/science.1142364
   PubMed Web of Science ®Google Scholar
• Nielsen J, Christiansen J, Lykke-andersen J, Johnsen AH, Wewer UM, Nielsen FC. A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development. Mol Cell Biol. 1999;19(2):1262–1270. doi:10.1128/MCB.19.2.1262
   PubMed Web of Science ®Google Scholar
• Ullrich S, Su J, Ranta F, et al. Effects of I Ks channel inhibitors in insulin-secreting INS-1 cells. Pflugers Arch. 2005;451(3):428–436. doi:10.1007/s00424-005-1479-2
   PubMedGoogle Scholar
• Barhanin J, Lesage F, Guillemare E, Fink M, Lazdunski M, Romey G. K V LQT1 and IsK (minK) proteins associate to form the I Ks cardiac potassium current. Nature. 1996;384(6604):78. doi:10.1038/384078a0
   PubMedGoogle Scholar
• Neyroud N, Tesson F, Denjoy I, et al. A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome. Nat Genet. 1997;15(2):186. doi:10.1038/ng0297-186
   PubMedGoogle Scholar
• Larsen LA, Fosdal I, Andersen PS, et al. Recessive Romano-Ward syndrome associated with compound heterozygosity for two mutations in the KVLQT1 gene. Eur J Hum Genet. 1999;7(6):724. doi:10.1038/sj.ejhg.5200323
   PubMedGoogle Scholar
• Zhou Y, Park S-Y, Su J, et al. TCF7L2 is a master regulator of insulin production and processing. Hum Mol Genet. 2014;23(24):6419–6431. doi:10.1093/hmg/ddu359
   PubMed Web of Science ®Google Scholar
• Elbein S, Chu W, Das S, et al. Transcription factor 7-like 2 polymorphisms and type 2 diabetes, glucose homeostasis traits and gene expression in US participants of European and African descent. Diabetologia. 2007;50(8):1621–1630. doi:10.1007/s00125-007-0717-x
   PubMed Web of Science ®Google Scholar
• McCarthy MI. Genomics, type 2 diabetes, and obesity. N Engl J Med. 2010;363(24):2339–2350. doi:10.1056/NEJMra0906948
   PubMed Web of Science ®Google Scholar
• Lindgren CM, Heid IM, Randall JC, et al. Genome-wide association scan meta-analysis identifies three loci influencing adiposity and fat distribution. PLoS Genet. 2009;5(6):e1000508. doi:10.1371/journal.pgen.1000508
   PubMed Web of Science ®Google Scholar
• Hotta K, Kitamoto T, Kitamoto A, et al. Association of variations in the FTO, SCG3 and MTMR9 genes with metabolic syndrome in a Japanese population. J Hum Genet. 2011;56(9):647. doi:10.1038/jhg.2011.74
   PubMed Web of Science ®Google Scholar
• Chauhan G, Tabassum R, Mahajan A, et al. Common variants of FTO and the risk of obesity and type 2 diabetes in Indians. J Hum Genet. 2011;56(10):720. doi:10.1038/jhg.2011.87
   PubMed Web of Science ®Google Scholar
• Peng S, Zhu Y, Xu F, Ren X, Li X, Lai M. FTO gene polymorphisms and obesity risk: a meta-analysis. BMC Med. 2011;9(1):71. doi:10.1186/1741-7015-9-71
   PubMedGoogle Scholar
• Chang Y-C, Liu P-H, Yu Y-H, et al. Validation of type 2 diabetes risk variants identified by genome-wide association studies in Han Chinese population: a replication study and meta-analysis. PLoS One. 2014;9(4):e95045. doi:10.1371/journal.pone.0095045
   PubMedGoogle Scholar
• Xiao S, Zeng X, Quan L, Zhu J. Correlation between polymorphism of FTO gene and type 2 diabetes mellitus in Uygur people from northwest China. Int J Clin Exp Med. 2015;8(6):9744.
   PubMedGoogle Scholar
• Loos RJ, Yeo GS. The bigger picture of FTO—the first GWAS-identified obesity gene. Nat Rev Endocrinol. 2014;10(1):51. doi:10.1038/nrendo.2013.227
   PubMed Web of Science ®Google Scholar
• Chambers JC, Elliott P, Zabaneh D, et al. Common genetic variation near MC4R is associated with waist circumference and insulin resistance. Nat Genet. 2008;40(6):716. doi:10.1038/ng.156
   PubMed Web of Science ®Google Scholar
• Meyre D, Delplanque J, Chèvre J-C, et al. Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations. Nat Genet. 2009;41(2):157. doi:10.1038/ng.301
   PubMed Web of Science ®Google Scholar
• Lyssenko V, Nagorny CL, Erdos MR, et al. Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nat Genet. 2009;41(1):82. doi:10.1038/ng.288
   PubMed Web of Science ®Google Scholar
• Bouatia-naji N, Bonnefond A, Cavalcanti-proença C, et al. A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk. Nat Genet. 2009;41(1):89. doi:10.1038/ng.277
   PubMed Web of Science ®Google Scholar
• Patel R, Rathwa N, Palit SP, Ramachandran A, Begum R. Association of melatonin & MTNR1B variants with type 2 diabetes in Gujarat population. Biomed Pharmacother. 2018;103:429–434. doi:10.1016/j.biopha.2018.04.058
   PubMed Web of Science ®Google Scholar
• Karamitri A, Jockers R. Melatonin in type 2 diabetes mellitus and obesity. Nat Rev Endocrinol. 2019;15(2):105–125. doi:10.1038/s41574-018-0130-1
   PubMed Web of Science ®Google Scholar
• Sladek R, Rocheleau G, Rung J, et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature. 2007;445(7130):881. doi:10.1038/nature05616
   PubMed Web of Science ®Google Scholar
• Cauchi S, Del Guerra S, Choquet H, et al. Meta-analysis and functional effects of the SLC30A8 rs13266634 polymorphism on isolated human pancreatic islets. Mol Genet Metab. 2010;100(1):77–82. doi:10.1016/j.ymgme.2010.01.001
   PubMedGoogle Scholar
• El Dib R, Gameiro OL, Ogata MS, et al. Zinc supplementation for the prevention of type 2 diabetes mellitus in adults with insulin resistance. Cochrane Database Syst Rev. 2015;5:CD005525.
   Google Scholar
• Shan Z, Bao W, Zhang Y, et al. Interactions between zinc transporter-8 gene (SLC30A8) and plasma zinc concentrations for impaired glucose regulation and type 2 diabetes. Diabetes. 2014;63(5):1796–1803. doi:10.2337/db13-0606
   PubMedGoogle Scholar
• Steinthorsdottir V, Thorleifsson G, Reynisdottir I, et al. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet. 2007;39(6):770. doi:10.1038/ng2043
   PubMed Web of Science ®Google Scholar
• Pierrel F, Douki T, Fontecave M, Atta M. MiaB protein is a bifunctional radical-S-adenosylmethionine enzyme involved in thiolation and methylation of tRNA. J Biol Chem. 2004;279(46):47555–47563. doi:10.1074/jbc.M408562200
   PubMedGoogle Scholar
• Wei F-Y, Suzuki T, Watanabe S, et al. Deficit of tRNA Lys modification by Cdkal1 causes the development of type 2 diabetes in mice. J Clin Invest. 2011;121:9. doi:10.1172/JCI58056
   Google Scholar
• Kang ES, Kim MS, Kim YS, et al. A polymorphism in the zinc transporter gene SLC30A8 confers resistance against posttransplantation diabetes mellitus in renal allograft recipients. Diabetes. 2008;57(4):1043–1047. doi:10.2337/db07-0761
   PubMed Web of Science ®Google Scholar
• Rutter GA. Think zinc: new roles for zinc in the control of insulin secretion. Islets. 2010;2(1):49–50. doi:10.4161/isl.2.1.10259
   PubMed Web of Science ®Google Scholar
• Xiang J, Li X-Y, Xu M, et al. Zinc transporter-8 gene (SLC30A8) is associated with type 2 diabetes in Chinese. J Clin Endocrinol Metab. 2008;93(10):4107–4112. doi:10.1210/jc.2008-0161
   PubMedGoogle Scholar
• Chimienti F, Favier A, Seve M. ZnT-8, a pancreatic beta-cell-specific zinc transporter. Biometals. 2005;18(4):313–317. doi:10.1007/s10534-005-3687-9
   PubMed Web of Science ®Google Scholar
• Scott LJ, Mohlke KL, Bonnycastle LL, et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. science. 2007;316(5829):1341–1345. doi:10.1126/science.1142382
   PubMed Web of Science ®Google Scholar
• Saxena R, Voight BF, Lyssenko V, et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science. 2007;316(5829):1331–1336. doi:10.1126/science.1142358
   PubMed Web of Science ®Google Scholar
• Sparsø T, Grarup N, Andreasen C, et al. Combined analysis of 19 common validated type 2 diabetes susceptibility gene variants shows moderate discriminative value and no evidence of gene–gene interaction. Diabetologia. 2009;52(7):1308–1314. doi:10.1007/s00125-009-1362-3
   PubMedGoogle Scholar
• Cauchi S, El Achhab Y, Choquet H, et al. TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis. J Mol Med. 2007;85(7):777–782. doi:10.1007/s00109-007-0203-4
   PubMed Web of Science ®Google Scholar
• Xu K, Zha M, Wu X, et al. Association between rs13266634 C/T polymorphisms of solute carrier family 30 member 8 (SLC30A8) and type 2 diabetes, impaired glucose tolerance, type 1 diabetes—a meta-analysis. Diabetes Res Clin Pract. 2011;91(2):195–202. doi:10.1016/j.diabres.2010.11.012
   PubMedGoogle Scholar
• Jing Y, Sun Q, Bi Y, Shen S, Zhu D. SLC30A8 polymorphism and type 2 diabetes risk: evidence from 27 study groups. Nutr Metab Cardiovasc Dis. 2011;21(6):398–405. doi:10.1016/j.numecd.2009.11.004
   PubMedGoogle Scholar
• Chauhan G, Spurgeon CJ, Tabassum R, et al. Impact of common variants of PPARG, KCNJ11, TCF7L2, SLC30A8, HHEX, CDKN2A, IGF2BP2, and CDKAL1 on the risk of type 2 diabetes in 5164 Indians. Diabetes. 2010;59(8):2068–2074. doi:10.2337/db09-1386
   PubMed Web of Science ®Google Scholar
• Han X, Luo Y, Ren Q, et al. Implication of genetic variants near SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, FTO, TCF2, KCNQ1, and WFS1 in type 2 diabetes in a Chinese population. BMC Med Genet. 2010;11(1):81. doi:10.1186/1471-2350-11-81
   PubMedGoogle Scholar
• Alami FM, Ahmadi M, Bazrafshan H, et al. Association of the TCF7L2 rs12255372 (G/T) variant with type 2 diabetes mellitus in an Iranian population. Genet Mol Biol. 2012;35(2):413–417. doi:10.1590/S1415-47572012005000029
   PubMedGoogle Scholar
• Shokouhi S, Delpisheh A, Haghani K, Mahdizadeh M, Bakhtiyari S. Association of rs7903146, rs12255372, and rs290487 polymorphisms in TCF7L2 gene with type 2 diabetes in an Iranian Kurdish ethnic group. Clin Lab. 2014;60(8):1269–1276. doi:10.7754/Clin.Lab.2013.130809
   PubMedGoogle Scholar
• Saadi H, Nagelkerke N, Carruthers SG, et al. Association of TCF7L2 polymorphism with diabetes mellitus, metabolic syndrome, and markers of beta cell function and insulin resistance in a population-based sample of Emirati subjects. Diabetes Res Clin Pract. 2008;80(3):392–398. doi:10.1016/j.diabres.2008.01.008
   PubMed Web of Science ®Google Scholar
• Alsmadi O, Al-rubeaan K, Mohamed G, et al. Weak or no association of TCF7L2 variants with Type 2 diabetes risk in an Arab population. BMC Med Genet. 2008;9(1):72. doi:10.1186/1471-2350-9-72
   PubMedGoogle Scholar
• Chang Y-C, Chang T-J, Jiang Y-D, et al. Association study of the genetic polymorphisms of the transcription factor 7-like 2 (TCF7L2) gene and type 2 diabetes in the Chinese population. Diabetes. 2007;56(10):2631–2637. doi:10.2337/db07-0421
   PubMed Web of Science ®Google Scholar
• Yen C-J, Beamer BA, Negri C, et al. Molecular scanning of the human peroxisome proliferator activated receptor γ (hPPARγ) gene in diabetic Caucasians: identification of a Pro12Ala PPARγ2 missense mutation. Biochem Biophys Res Commun. 1997;241(2):270–274. doi:10.1006/bbrc.1997.7798
   PubMed Web of Science ®Google Scholar